🌊 SNRIs – Serotonin–Norepinephrine Reuptake Inhibitors


What they are:

SNRIs are antidepressants that increase two brain chemicals: serotonin and norepinephrine. They can help with anxiety, depression, and certain pain conditions.


Common examples:

Duloxetine (Cymbalta)

Venlafaxine (Effexor)


Uses in kids and teens 🧠

Duloxetine is FDA-approved for Generalized Anxiety Disorder (GAD) in children 7–17 years old.

Sometimes used (off-label) for depression or chronic pain when other medications aren’t enough.


How they work:

SNRIs block the “reuptake pumps” for serotonin and norepinephrine, helping nerve cells communicate more steadily. Norepinephrine is tied to alertness, focus, and the body’s stress response – boosting it slightly can improve energy and concentration.


Stats & facts 📊

In U.S. adolescents, antidepressant use (mostly SSRIs, some SNRIs) sits around 4–5%, and SSRIs are usually tried first.

Evidence shows duloxetine improves anxiety scores more than placebo in youth with GAD.


Common side effects:

Nausea, dry mouth

Sleep changes (tiredness or insomnia)

Headaches

Increased sweating

Sometimes a temporary increase in anxiety in the first weeks


Safety notes for families ⚠️

Like SSRIs, SNRIs carry the suicidality black-box warning in people under 25. Families should watch for new agitation, dark thoughts, or behavior changes and contact the prescriber right away.

SNRIs can raise blood pressure or heart rate in some people, so doctors may check vitals regularly.


References (SNRIs):

Dwyer, J. B., et al. (2019). Antidepressants for pediatric patients. Child and Adolescent Psychiatric Clinics.

U.S. FDA. (2020). CYMBALTA (duloxetine) label – Pediatric GAD indication.